Welcoming by Design Pilot: Reducing Structural Stigma by Changing Clinic Systems and Architectural Design
Launched by UNIVERSITY OF MINNESOTA · Nov 29, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
The "Welcoming by Design Pilot" is a study aimed at making HIV clinics in Uganda more welcoming and comfortable for patients. This involves changing how the clinics are set up and improving the physical spaces to help reduce stigma around HIV, which can sometimes make patients feel unwelcome. The goal is to see if these changes can help patients stay engaged in their care and have a better overall experience at the clinic. Researchers will look at how well these new designs work and whether they cause any issues for the clinic staff or operations.
To participate in this study, you need to be an adult aged 18 or older who is receiving care at one of the clinics involved. You should be able to understand and provide consent for interviews or surveys, and you need to speak either English or Luganda, which is the local language. If you join the study, you can expect to share your thoughts and experiences about the changes made in the clinic, helping to shape a better environment for current and future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 18 and older
- • Enrolled in the HIV clinics where we are working
- • Able to independently consent for interview, survey, or focus group.
- Exclusion Criteria:
- • Unable to provide consent
- • Does not speak English or Luganda (local language around Kampala and Entebbe)
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minneapolis, Minnesota, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials